Oncology & Cancer

Men say they want prostate cancer test, despite risks

A survey of men age 40 to 74 found that 54 percent said that they would still opt for a popular prostate cancer screening test despite recent recommendations that the test not be performed, finds a new study in American Journal ...

Oncology & Cancer

Many men not told pros, cons of PSA testing, survey finds

(HealthDay)—Many doctors insulate their patients from the complexities surrounding the PSA test, and instead decide on their own whether to screen for prostate cancer or not, a new study finds.

Oncology & Cancer

Doctors differ on prostate screening

Prostate screening tests detect prostate cancer early, but questions about whether the tests do more harm than good have made them one of the most hotly debated areas of medicine.

Oncology & Cancer

Prostate cancer may be deadlier for the uninsured

(HealthDay)—Men who are uninsured or underinsured get advanced prostate cancer at nearly four times the national average and don't survive as long as other men with advanced disease, a new study says.

Oncology & Cancer

Study questions value of PSA test for older men

(HealthDay)—Only one-third of men over age 65 who receive an abnormal result from their PSA test actually undergo prostate biopsy to look for disease, a new study finds.

Genetics

Scientists find new gene markers for cancer risk

A huge international effort involving more than 100 institutions and genetic tests on 200,000 people has uncovered dozens of signposts in DNA that can help reveal further a person's risk for breast, ovarian or prostate cancer, ...

page 8 from 14